A new rapid one-step immunochromatographic test using monoclonal antibodies for detection of Helicobacter pylori antigen in stool in children was evaluated on coded stool samples from 159 children (mean age, 9.7 ؎ 5.0 years; 118 from Munich, 41 from Vienna): 86 children were H. pylori infected defined by positive culture and/or >2 other positive tests ( Helicobacter pylori infection is the major cause of peptic ulcer disease and chronic gastritis and is almost always acquired in early childhood. For the diagnosis of H. pylori infection, gastrointestinal endoscopy with concordant results of biopsy based methods (culture, histology, and rapid urease test) is considered to be the "gold standard." Several noninvasive methods for the detection of H. pylori infection are available. In children, tests must be reliable in all age groups (8). Most serological tests show a low sensitivity in young children (5,7,8,19). The [ 13 C]urea breath test (UBT) gives an excellent performance, in both, adults and children, but specificity decreases in very young children, and collection of exhaled air is difficult in this age group (2, 6). Recently an enzyme immunoassay (EIA) based on polyclonal antibodies was developed for detection of H. pylori antigen in stool. Results of different studies showed conflicting results indicating large test to test variability, both pre-and posttreatment in children and adults (4,10,13,(16)(17)(18). In contrast, stool EIA based on monoclonal antibodies showed excellent results, with very high sensitivity and specificity (9, 13). The Immunocard STAT! HpSA (Meridian Bioscience Europe) is a novel one-step immunochromatographic quick test based on detection of monoclonal antibodies to H. pylori antigen in feces. The aim of this study was to evaluate this test for detection of H. pylori infection in a large number of children before and after H. pylori eradication therapy in comparison to a well-defined H. pylori status established by the results of invasive diagnostic techniques and the UBT.
MATERIALS AND METHODS
Patients.For the evaluation prior to first therapy, 159 children (80 girls, 79 boys, mean age 9.7 Ϯ 5.0 years) were enrolled in two pediatric hospitals (Munich, n ϭ 118; Vienna, n ϭ 41). All children underwent upper gastrointestinal endoscopy because of abdominal symptoms suggestive of organic disease. None of the children had been treated for H. pylori infection in the past. Children were excluded if they took antibiotic or acid-suppressive drugs (proton pump inhibitors, H 2 -receptor antagonists, antacids, bismuth preparations) within 4 weeks prior to testing, if they had diarrhea, or if the H. pylori status was not clearly defined as described below. In our centers, about 1 out of 9 children undergoing upper endoscopy is H. pylori infected. To have a meaningful number of H. pylori-infected patients in relation to the total number of tests performed, we included all H. pylori-positive children who fulfilled the inclusion criteria and selected randomly an equal number of noninfected children f...